WuXi PharmaTech (Cayman) Inc. Depreciation and Amortization Expense
WuXi PharmaTech (Cayman) Inc. reported Depreciation and Amortization Expense of $46.36 million for the 12-month period ending 2014-12-31, per its 20-F filed 2015-04-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DepreciationAndAmortization · last filed 2015-04-15
| Period end | Depreciation, Depletion and Amortization, Nonproduction 12 month |
|---|---|
| 2014-12-31 | $46.36M 20-F · filed 2015-04-15 |
| 2013-12-31 | $44.74M 20-F · filed 2015-04-15 |
| 2012-12-31 | $41.67M 20-F · filed 2015-04-15 |
| 2011-12-31 | $34.00M 20-F · filed 2014-04-15 |
| 2010-12-31 | $29.21M 20-F · filed 2013-04-17 |
| 2009-12-31 | $23.97M 20-F · filed 2012-04-20 |
| 2008-12-31 | $31.04M 20-F · filed 2011-04-27 |